The first CRISPR Therapeutics and Vertex collaboration to treat sickle cell disease (SCD), as well as β-thalassemia, was placed on a clinical hold by the FDA earlier this year. The stock for CRISPR Therapeutics and other gene editing companies have been … Continue reading First CRISPR-Cas9 Human Trial Lifted from Clinical Hold
Japan’s health and science ministries has created a draft proposal for turning the country’s current lack of position on editing human embryos to a position which encourages the practice. The draft proposal would still restrict editing human embryos bound for … Continue reading Japan to Promote Editing DNA of Human Embryos
Scientists at the Cold Spring Harbor Laboratory in New York have used CRISPR-Cas9 to increase the size and production capacity of the groundcherry (Physalis pruinosa), a fruit native to the American tropics. The researchers are confident that they can use … Continue reading CRISPR Creates New Type of Cherry (Sort of)
KSQ Therapeutics has secured $80 million to further advance its cancer treatment portfolio. The startup is unique for using CRISPR-Cas9 at a large enough scale that it has discovered 12 potential cancer treatments in the last year. KSQ calls their … Continue reading Startup Seeks to Bring a Slew of Cancer Treatments to Market Thanks to CRISPR
Researchers at the Imperial College London in the UK have successfully used a gene drive to completely suppress a population of malaria prone mosquitoes in the lab. A gene drive is a genetic engineering technology that can propagate a particular suite of … Continue reading Scientists Use Gene Drive to Destroy Mosquito Population
TheFutureGist 